1. Text Size:
  2. Contrast:

Login

Please note that ASWCS will cease to exist in its current format on 31 March 2013. From 31 March 2013 this site will be an archive site which will not be updated except for the chemotherapy protocols. The site will be removed in September 2013

Welcome to the Avon, Somerset & Wiltshire Cancer Research Network - Avon Somerset and Wiltshire Cancer Services

Welcome to the Avon, Somerset & Wiltshire Cancer Research Network

About ASWCRN

The Cancer Research Network was formed in 2001 and was one of the first wave of research networks established by the Department of Health across the country.  The English cancer research networks are overseen by the National Cancer Research Network (NCRN) and work closely with the Welsh, Scottish and Northern Irish Cancer Research Networks. 

The principal aims of the network are to improve the speed, quality and co-ordination of research across the cancer network; and thus ultimately to improve patient care.  The target set by the Department of Health for the research networks to help achieve these aims was to double the number of patients entering clinical trials in the first 3 years (so that 7.5% of those estimated to have cancer are taking part in clinical trials).  This target was met locally within 1 year and nationally has now been surpassed.  The Cancer Research Network is fully integrated into the Avon Somerset and Wiltshire Cancer Services. 

The Team

The network directly employs 32 staff and draws on the expertise of a large number of clinical research professionals to recruit patients into NCRN portfolio studies. The network funds research nurses, clinical trials officers, trial co-ordinators and data managers who are employed within local trusts.  Staff are based across the network in six acute Trusts:

 There are currently three core team members:

  • Clinical Lead for Research, Dr Stephen Falk
  • Research Network Manager, Catherine Carpenter-Clawson 
  • Network Administrator, Sarah Redka

Achievements of the ASWCRN

Prior to the inception of the NCRN, the network area already had experience and expertise in cancer clinical trials.  From 1 April 2001 to 31 March 2002, 5% of cancer & pre-malignant patients were taking part in clinical trials.  Since then the research network has increased and maintained its capacity and in 2009-10, 16.6% of those individuals in the region were entering clinical trials and other studies in the NIHR portfolio.  This exceeds both the Department of Health target of 7.5% and the National Cancer Research Network target of 10%.

The research network received positive feedback during the Cancer Services peer-review process in 2010 with recognition of good practice across the tumour groups and strong leadership. 

Content of the ASWCRN Webpages

 On the following webpages you can find:

We would like to place cookies on your computer to make your experience of our website faster and more convenient. To find out more, please refer to our Privacy Policy.

Please choose a setting: